Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.09.2020 | Case report

Methotrexate

Pneumonitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Pampin R, et al. Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma. Journal of Oncology Pharmacy Practice 26: 549-555, No. 3, Apr 2020. Available from: URL: http://doi.org/10.1177/1078155219852412 Pampin R, et al. Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma. Journal of Oncology Pharmacy Practice 26: 549-555, No. 3, Apr 2020. Available from: URL: http://​doi.​org/​10.​1177/​1078155219852412​
Metadaten
Titel
Methotrexate
Pneumonitis: case report
Publikationsdatum
01.09.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-83548-y

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Rifampicin

Case report

Multiple drugs

Case report

Acetazolamide

Case report

Multiple drugs